Pharming Group: question of potential




By




Pharma Group rises 0.5% to 1.05 euros this Wednesday, as the company announced the expansion of its product portfolio for rare diseases with plans to develop leniolisib for other primary immune deficiencies beyond activated phosphoinositide 3-kinase. syndrome…

This stock market news is reserved for subscribers Privileges


Test our stock market advice for €1, without obligation


I subscribe

Already subscribed? Log in

Discover Boursier.com services Privileges


  • 8:30 a.m.
    Today’s recce

  • 4 to 5 stock market tips per day


    4 to 5 tips
    scholarship holders per day

  • weekly letter “Opportunities”


    Weekly letter “Opportunities”



  • Wallets
    defensive, balanced
    and dynamic


Learn more


©2023 Boursier.com



Source link -87